Ozlo Secures Funding to Expand Clinical Sleep Research
The company plans to use the new funding to develop clinical-grade sleep tools for individuals managing conditions like tinnitus.
Updated on Oct. 29, 2026 in Sleep Disorders
Live Poll
Do you trust wearable technology companies to provide effective solutions for your sleep health?
Boston-based sleep technology company Ozlo has secured $22 million in Series B funding to advance its research into sleep health and clinical applications. The company, which recently launched its Sleepbuds 2, plans to use the capital to scale its global operations and expand into new nighttime health markets.
Why it matters
This investment signals a broader shift in the consumer sleep market toward integrating clinical-grade technologies like noise masking and tinnitus management. For users managing chronic sleep challenges, the development indicates a potential pipeline of new tools designed to bridge the gap between consumer devices and clinical sleep interventions.
Ozlo reported a successful $22 million Series B funding round, reaching a total of 260,000 customers in less than two years of operation. The effectiveness of their hardware in clinical settings and the timeline for upcoming FDA regulatory submissions remain under development.
The players
Ozlo
A Boston-based sleep technology company that develops hardware for noise masking and, currently, tinnitus management research.
Modi Ventures
A venture capital firm that led the latest funding round for the sleep technology manufacturer.
Dreem Health
A virtual sleep clinic that partners with technology developers to provide clinical support for sleep disorders.
The details
Ozlo develops sleep solutions by combining hardware design with intelligent noise masking and engineered audio. The company currently partners with the virtual sleep clinic Dreem Health to integrate these technologies into broader sleep management programs. Future development efforts are focused on expanding this platform to include clinical-grade tinnitus management tools.
Timeline
October 29, 2026: Ozlo announces its Series B funding round.
July 2026: The company releases the Sleepbuds 2, which feature 14 hours of battery life.
2025-2026: Ozlo receives industry recognition for its innovation and design.
Health Landscape
The move reflects a growing trend of consumer sleep companies seeking to validate their hardware through the FDA regulatory process for medical devices. This transition aims to move sleep technology beyond simple wellness tracking and into the clinical management of chronic conditions like tinnitus.
If you are exploring noise-masking devices for sleep, monitor clinical research updates regarding tinnitus treatments and device efficacy. These developments are best discussed with your doctor to determine if clinical-grade tools or virtual sleep clinics are appropriate for your health needs.
The takeaway
Sleep technology is increasingly moving toward clinical application, with new capital supporting research into conditions like tinnitus. Patients should track the emergence of FDA-cleared devices and consult their physician regarding which, if any, evidence-based sleep technologies fit their care plan.
Further reading
Learn more about the latest innovations in Sleep Disorders.
More information
For more details on the company's hardware and research initiatives, visit the Ozlo company information website.
Source note: This article includes information reported by The Manila times.
Live Poll
Do you trust wearable technology companies to provide effective solutions for your sleep health?
